A Dark Vector Cognition product

Item 16. Form 10-K Summary

4K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary

Not applicable.

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

DATE:February 24, 2022Regions Financial Corporation
By:/S/ JOHN M. TURNER, JR.
John M. Turner, Jr. President and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated

Table of Contents

SignatureTitleDate
/S/ JOHN M. TURNER, JR.President and Chief Executive Officer, and Director (principal executive officer)February 24, 2022
John M. Turner, Jr.
/S/ DAVID J. TURNER, JR.Senior Executive Vice President and Chief Financial Officer (principal financial officer)February 24, 2022
David J. Turner, Jr.
/S/ HARDIE B. KIMBROUGH, JR.Executive Vice President and Controller (principal accounting officer)February 24, 2022
Hardie B. Kimbrough, Jr.
*DirectorFebruary 24, 2022
Carolyn H. Byrd
*DirectorFebruary 24, 2022
Don DeFosset
*DirectorFebruary 24, 2022
Samuel A. Di Piazza, Jr.
*DirectorFebruary 24, 2022
Zhanna Golodryga
*DirectorFebruary 24, 2022
John D. Johns
*DirectorFebruary 24, 2022
Join M. Johnson
*DirectorFebruary 24, 2022
Ruth Ann Marshall
*DirectorFebruary 24, 2022
Charles D. McCrary
*DirectorFebruary 24, 2022
James T. Prokopanko
*DirectorFebruary 24, 2022
Lee J. Styslinger III
*DirectorFebruary 24, 2022
José S. Suquet
*DirectorFebruary 24, 2022
Timothy Vines

Table of Contents

  • Tara A. Plimpton, by signing her name hereto, does sign this document on behalf of each of the persons indicated above pursuant to powers of attorney executed by such persons and filed with the Securities and Exchange Commission.
By:/S/ Tara A. Plimpton
Tara A. Plimpton
Attorney in Fact

Previous: Item 15. Exhibits and Financial Statement Schedules